Shortage reports
Actual shortage:
257 (7%)
Anticipated shortage:
3 (0%)
Avoided shortage:
11 (0%)
Resolved:
3300 (92%)
3571
Discontinuation Reports
To be discontinued:
24 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
366
143 (4%)
32 (11%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-DILTIAZ CD | 120MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2017-03-10 | 2018-12-18 | 281 |
| APO-DILTIAZ CD | 300MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2019-03-05 | 2019-11-05 | 77872 |
| APO-DILTIAZ CD | 300MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2025-03-27 | 2025-04-17 | 253505 |
| APO-DILTIAZ CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2025-04-04 | 2025-04-17 | 254162 |
| APO-DILTIAZ CD | 120MG | CAPSULE (CONTROLLED-DELIVERY) CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2021-06-11 | 2021-08-31 | 140775 |
| APO-DILTIAZ CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2019-02-24 | 2019-07-12 | 76714 |
| APO-DILTIAZ CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2017-03-12 | 2018-12-18 | 716 |
| APO-DILTIAZ CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2019-03-13 | 2019-07-12 | 78484 |
| APO-DILTIAZ CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2019-02-06 | 2019-07-12 | 74872 |
| APO-DILTIAZ CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2025-11-27 | 2025-12-05 | 272632 |
| APO-DILTIAZ CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2019-08-21 | 2019-10-15 | 92022 |
| APO-DILTIAZ CD | 120MG | CAPSULE (CONTROLLED-DELIVERY) CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2023-07-27 | 2023-08-23 | 200197 |
| APO-DILTIAZ CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2020-11-19 | 2020-11-27 | 128594 |
| APO-DILTIAZ CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2019-08-07 | 2019-10-15 | 91073 |
| APO-DILTIAZ CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2017-06-28 | 2018-12-18 | 14168 |
| APO-DILTIAZ CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2021-02-26 | 2021-08-23 | 134811 |
| APO-DILTIAZ CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2024-10-04 | 2024-11-15 | 239367 |
| APO-DILTIAZ CD | 300MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2025-08-07 | 2025-12-05 | 264552 |
| APO-DILTIAZ CD | 300MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2024-10-24 | 2024-11-29 | 241075 |
| APO-DILTIAZ CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Resolved | 2019-09-04 | 2019-10-15 | 92965 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-BROMAZEPAM - TAB 1.5MG | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM - TAB 3MG | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM - TAB 6MG | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |